Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis
Daniel Harari, Nadine Kuhn, Renne Abramovich, Keren Sasson, Alla L. Zozulya, Paul Smith, Martin Schlapschy, Rina Aharoni, Mario Koester, Raya Eilam, Arne Skerra, Gideon Schreiber
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis'. Together they form a unique fingerprint.